IL-15 and macrophage secretory factors facilitate immune activation of neonatal natural killer cells by lipoteichoic acid

Cytokine

Volumn 61, Issue 2, 2013, Pages 499-505

  Cheng, Siu Fung ^a   Ho, Joanna Wen Ying ^a   Chan, Kathy Yuen Yee ^a   Leung, Tak Yeung ^a   Lam, Hugh Simon ^a   Fong, Oi Ning ^a   Li, Karen ^a   Ng, Pak Cheung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

IL 15; Lipoteichoic acid; Macrophages; Natural killer cells; Neonatal blood

Indexed keywords

CD56 ANTIGEN; CD69 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 6; LIPOTEICHOIC ACID; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MACROPHAGE ACTIVATING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MACROPHAGE; NATURAL KILLER CELL; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; WESTERN BLOTTING;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CULTURE MEDIA, CONDITIONED; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INTERLEUKIN-15; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MACROPHAGES; MALE; PHOSPHORYLATION; TEICHOIC ACIDS; YOUNG ADULT;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 84873145120     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.10.034     Document Type: Article

References (42)

1. Ng P.C., Ang I.L., Chiu R.W., Li K., Lam H.S., Wong R.P., et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010, 120:2989-3000.
2. Stoll B.J., Hansen N.I., ms-Chapman I., Fanaroff A.A., Hintz S.R., Vohr B., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292:2357-2365.
3. Marodi L. Innate cellular immune responses in newborns. Clin Immunol 2006, 118:137-144.
4. Paust S., Senman B., von Andrian U.H. Adaptive immune responses mediated by natural killer cells. Immunol Rev 2010, 235:286-296.
5. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004, 4:553-564.
6. Caligiuri M.A. Human natural killer cells. Blood 2008, 112:461-469.
7. Vankayalapati R., Garg A., Porgador A., Griffith D.E., Klucar P., Safi H., et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2005, 175:4611-4617.
8. Small C.L., McCormick S., Gill N., Kugathasan K., Santosuosso M., Donaldson N., et al. NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung. J Immunol 2008, 180:5558-5568.
9. Goodier M.R., Londei M. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. J Immunol 2000, 165:139-147.
10. Newman K.C., Riley E.M. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 2007, 7:279-291.
11. Haller D., Serrant P., Granato D., Schiffrin E.J., Blum S. Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes. Clin Diagn Lab Immunol 2002, 9:649-657.
12. Li W., Janowicz D.M., Fortney K.R., Katz B.P., Spinola S.M. Mechanism of human natural killer cell activation by Haemophilus ducreyi. J Infect Dis 2009, 200:590-598.
13. Le Garff-Tavernier M., Beziat V., Decocq J., Siguret V., Gandjbakhch F., Pautas E., et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 2010, 9:527-535.
14. Guilmot A., Hermann E., Braud V.M., Carlier Y., Truyens C. Natural killer cell responses to infections in early life. J Innate Immun 2011, 3:280-288.
15. Nguyen Q.H., Roberts R.L., Ank B.J., Lin S.J., Lau C.K., Stiehm E.R. Enhancement of antibody-dependent cellular cytotoxicity of neonatal cells by interleukin-2 (IL-2) and IL-12. Clin Diagn Lab Immunol 1998, 5:98-104.
16. Peoples J.D., Cheung S., Nesin M., Lin H., Tatad A.M., Hoang D., et al. Neonatal cord blood subsets and cytokine response to bacterial antigens. Am J Perinatol 2009, 26:647-657.
17. Hoshina T., Kida K., Ito M. Difference in response of NK cell activity in newborns and adult to IL-2, IL-12 and IL-15. Microbiol Immunol 1999, 43:161-166.
18. Sundstrom Y., Nilsson C., Lilja G., Karre K., Troye-Blomberg M., Berg L. The expression of human natural killer cell receptors in early life. Scand J Immunol 2007, 66:335-344.
19. Ng P.C., Li K., Leung T.F., Wong R.P., Li G., Chui K.M., et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem 2006, 52:1181-1189.
20. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110:285-291.
21. Chan K.Y., Xiang P., Zhou L., Li K., Ng P.C., Wang C.C., et al. Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks. Eur J Heart Fail 2011, 13:366-376.
22. Alter G., Malenfant J.M., Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004, 294:15-22.
23. Thorley A.J., Grandolfo D., Lim E., Goldstraw P., Young A., Tetley T.D. Innate immune responses to bacterial ligands in the peripheral human lung-role of alveolar epithelial TLR expression and signalling. PLoS One 2011, 6:e21827.
24. Chang H.C., Lin K.H., Tai Y.T., Chen J.T., Chen R.M. Lipoteichoic acid-induced TNF-alpha and IL-6 gene expressions and oxidative stress production in macrophages are suppressed by ketamine through downregulating Toll-like receptor 2-mediated activation oF ERK1/2 and NFkappaB. Shock 2010, 33:485-492.
25. Chambers K.A., Parks R.J., Angel J.B. Disruption of MAP kinase activation and nuclear factor binding to the IL-12 p40 promoter in HIV-infected myeloid cells. Clin Exp Immunol 2004, 137:329-340.
26. Ng P.C., Li K., Chui K.M., Leung T.F., Wong R.P., Chu W.C., et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res 2007, 61:93-98.
27. Su S.C., Hua K.F., Lee H., Chao L.K., Tan S.K., Lee H., et al. LTA and LPS mediated activation of protein kinases in the regulation of inflammatory cytokines expression in macrophages. Clin Chim Acta 2006, 374:106-115.
28. Scull C.M., Hays W.D., Fischer T.H. Macrophage pro-inflammatory cytokine secretion is enhanced following interaction with autologous platelets. J Inflamm (Lond) 2010, 7:53.
29. Lin W.J., Yeh W.C. Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. Shock 2005, 24:206-209.
30. Diao H., Kohanawa M. Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect Immun 2005, 73:3745-3748.
31. Kaji R., Kiyoshima-Shibata J., Nagaoka M., Nanno M., Shida K. Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol 2010, 184:3505-3513.
32. Ma X., Trinchieri G. Regulation of interleukin-12 production in antigen-presenting cells. Adv Immunol 2001, 79:55-92.
33. Tomescu C., Chehimi J., Maino V.C., Montaner L.J. Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-alpha by human NK cells after CD107a degranulation. J Leukocyte Biol 2009, 85:871-876.
34. Bouzani M., Ok M., McCormick A., Ebel F., Kurzai O., Morton C.O., et al. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-gamma release. J Immunol 2011, 187:1369-1376.
35. Clausen J., Vergeiner B., Enk M., Petzer A.L., Gastl G., Gunsilius E. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiology 2003, 207:85-93.
36. Vosshenrich C.A., Ranson T., Samson S.I., Corcuff E., Colucci F., Rosmaraki E.E., et al. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 2005, 174:1213-1221.
37. Cooper M.A., Bush J.E., Fehniger T.A., VanDeusen J.B., Waite R.E., Liu Y., et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 2002, 100:3633-3638.
38. Choi S.S., Chhabra V.S., Nguyen Q.H., Ank B.J., Stiehm E.R., Roberts R.L. Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture. Clin Diagn Lab Immunol 2004, 11:879-888.
39. Lin S.J., Chao H.C., Kuo M.L. The effect of interleukin-12 and interleukin-15 on CD69 expression of T-lymphocytes and natural killer cells from umbilical cord blood. Biol Neonate 2000, 78:181-185.
40. Nathan C.F. Secretory products of macrophages. J Clin Invest 1987, 79:319-326.
41. Qian J.X., Lee S.M., Suen Y., Knoppel E., van de Ven C., Cairo M.S. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 1997, 90:3106-3117.
42. Yuan T.M., Sun Y., Zhan C.Y., Yu H.M. Intrauterine infection/inflammation and perinatal brain damage: role of glial cells and Toll-like receptor signaling. J Neuroimmunol 2010, 229:16-25.